[{"address1": "4660 La Jolla Village Drive", "address2": "Suite 100", "city": "San Diego", "state": "CA", "zip": "92122", "country": "United States", "phone": "650 800 3717", "website": "https://www.revbiosciences.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Revelation Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of immune system therapeutics and diagnostics. It engages in developing therapeutic product candidates, including GEM-SSI, a potential therapy for the prevention and treatment of surgical sit infection; GEM-AKI, a potential therapy for the prevention and treatment of acute kidney injury; and GEM-CKD, a potential therapy for the prevention and treatment of chronic kidney disease. The company was founded in 2020 and is based in San Diego, California.", "fullTimeEmployees": 9, "companyOfficers": [{"maxAge": 1, "name": "Mr. James M. Rolke", "age": 55, "title": "CEO & Director", "yearBorn": 1969, "fiscalYear": 2023, "totalPay": 649250, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Chester Stanley Zygmont III", "age": 44, "title": "CFO & Corporate Secretary", "yearBorn": 1980, "fiscalYear": 2023, "totalPay": 479141, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Sandra  Vedrick", "title": "Vice President of Human Resources & Investor Relations", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Carol  Odle", "title": "Senior Director of Clinical Projects", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 4, "previousClose": 4.16, "open": 4.24, "dayLow": 4.17, "dayHigh": 4.45, "regularMarketPreviousClose": 4.16, "regularMarketOpen": 4.24, "regularMarketDayLow": 4.17, "regularMarketDayHigh": 4.45, "beta": 0.194, "forwardPE": -0.12578987, "volume": 69426, "regularMarketVolume": 69426, "averageVolume": 236454, "averageVolume10days": 117930, "averageDailyVolume10Day": 117930, "bid": 3.17, "ask": 5.37, "bidSize": 200, "askSize": 200, "marketCap": 2235358, "fiftyTwoWeekLow": 3.34, "fiftyTwoWeekHigh": 69.44, "fiftyDayAverage": 6.25448, "twoHundredDayAverage": 18.00346, "currency": "USD", "enterpriseValue": -5392822, "floatShares": 222979, "sharesOutstanding": 522280, "sharesShort": 63430, "sharesShortPriorMonth": 15022, "sharesShortPreviousMonthDate": 1735603200, "dateShortInterest": 1738281600, "sharesPercentSharesOut": 0.121400006, "heldPercentInsiders": 0.00035, "heldPercentInstitutions": 0.12099, "shortRatio": 0.13, "shortPercentOfFloat": 0.12149999, "impliedSharesOutstanding": 522280, "bookValue": 9.966, "priceToBook": 0.4294602, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1727654400, "netIncomeToCommon": -15515720, "trailingEps": -280.48, "forwardEps": -2.33, "lastSplitFactor": "1:16", "lastSplitDate": 1738022400, "enterpriseToEbitda": 0.633, "52WeekChange": -0.9081272, "SandP52WeekChange": 0.22903383, "exchange": "NCM", "quoteType": "EQUITY", "symbol": "REVB", "underlyingSymbol": "REVB", "shortName": "Revelation Biosciences, Inc.", "longName": "Revelation Biosciences, Inc.", "firstTradeDateEpochUtc": 1605623400, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EST", "uuid": "f994477e-3690-3dde-965e-6f9faa0f03d6", "messageBoardId": "finmb_696222591", "gmtOffSetMilliseconds": -18000000, "currentPrice": 4.28, "targetHighPrice": 320.0, "targetLowPrice": 21.45, "targetMeanPrice": 170.725, "targetMedianPrice": 170.725, "recommendationKey": "none", "numberOfAnalystOpinions": 2, "totalCash": 6541052, "totalCashPerShare": 24.382, "ebitda": -8520147, "quickRatio": 1.609, "currentRatio": 1.637, "returnOnAssets": -0.50976, "returnOnEquity": -2.7002301, "freeCashflow": -6497144, "operatingCashflow": -16576471, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2025-02-15"}]